Beximco Pharmaceuticals Limited (BST:R2WA)
0.5000
-0.0650 (-11.50%)
At close: Sep 26, 2025
Beximco Pharmaceuticals Market Cap
Beximco Pharmaceuticals has a market cap or net worth of €382.55 million as of September 26, 2025. Its market cap has increased by 50.26% in one year.
Market Cap
382.55M
Enterprise Value
433.86M
Revenue
373.79M
Ranking
n/a
PE Ratio
7.46
Stock Price
€0.50
Market Cap Chart
Since January 3, 2000, Beximco Pharmaceuticals's market cap has increased from 36.78M to 382.55M, an increase of 940.21%. That is a compound annual growth rate of 9.52%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 25, 2025 | 382.55M | 30.84% |
Dec 30, 2024 | 292.37M | -45.57% |
Dec 28, 2023 | 537.15M | -9.71% |
Dec 29, 2022 | 594.94M | -33.15% |
Dec 30, 2021 | 889.99M | 9.12% |
Dec 30, 2020 | 815.57M | 175.99% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 262.21B |
Siemens Aktiengesellschaft | 177.42B |
Deutsche Telekom AG | 136.77B |
Allianz SE | 136.28B |
Rheinmetall AG | 89.95B |
Siemens Energy AG | 84.11B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.76B |
Deutsche Bank Aktiengesellschaft | 58.48B |